The phoney financial markets currently flirting with record highs and the underlying real economy struggling with earnings and job growth are exhibiting unparalleled paradox. Domestic benchmark equity index Nifty is trading at a PE multiple of 24 while small-cap index trades at 70, three-times the valuation premium. There is another divergence: Companies are queuing at the Insolvency and Bankruptcy Board of India (IBBI) filing for corporate insolvency resolution plan (CIRP), aka Chapter-11 bankrupcy filings in the US.
We also know the party is at its peak when it’s just about to end.
History provides enough proof the weakest investors join the euphoria at the end of the bull market. This bull market has run its course for eight years since the March 2009 lows and is throwing signs that the ride for equity investors from mount-9300 Nifty onwards may be very challenging.
Not withstanding government high-decibel propaganda on the state of the economy, corporate earnings growth is missing, jobs are elusive but consumer goods and asset prices are steadily rising. Since the turn of the year, bankruptcy is a new buzz-word in banking circles as corporates line up for insolvency and bankruptcy filing.
Bankers perhaps never had such a bad time ever in the past, and corporates never so good. Banks want to rid themselves of the non-performing assets (NPA) to clean up their books to do fresh business and failed corporates are too eager to obtain a favourable hair-cut of their outstanding loans and clean-chit to re-start new ventures. During the first four months of 2017, about 60 companies have already knocked on the doors of the National Company Law Tribunal (NCLT) for Insolvency Restructuring Plan. These include some well-known names. Practitioners say the number is likely to touch 1,000 by next summer and perhaps 5,000 by the time Mr Narendra Modi seeks re-election in 2019.
Steel, power, textiles, infrastructure and chemicals are likely to dominate the list of failed companies seeking bankruptcy proceedings. The sunrise sector of the recent past, telecom, is also likely to show up for seeking a hair-cut. Paradoxically, some of these companies are traded on the markets and investors hoarding these shares assuming there is fire left in these stocks. They will be dealt a rude shock.
Ridding bank balance sheets of stressed asset are key to reviving credit growth. Without this the government can’t go ahead with its many plans. The foremost amongst them all is the creation of more jobs. Various schemes proposed by RBI to resolve the problem have been unsuccessful, with lenders reluctant to write down assets sufficiently and company owners unwilling to negotiate repayment plans.
How situation got worsened?
この記事は Indian Economy & Market の May 2017 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Indian Economy & Market の May 2017 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
WORLD DEVELOPMENT REPORT 2024 THE MIDDLE-INCOME TRAP
A World Bank report titled 'World Development Report 2024: The Middle-Income Trap' indicates that India may take up to 75 years to attain just a quarter of the United States' per capita income. The insights in the report provides a useful reality check for India's ambitious goals, such as becoming a developed economy by 2047 or reaching a $5 trillion economy within the next three years.
IN CONVERSATION: "We are working with a Vision 2035. I'm sure within next 5 years we will be ranking among the Fortune 500 companies.”
Sudarshan Pharma Industries Ltd., led by its promoters, Mr. Hemal V. Mehta, a chemical engineer, and Mr. Sachin V. Mehta, has established a strong foundation in specialty chemicals and bulk drugs. Their relentless enthusiasm is visible when they speak. Indian Economy & Market reached out, to piece together the company's achievements and new initiatives in detail.
Sudarshan Pharma Industries Ltd. A MULTIBAGGER IN MAKING
Sudarshan Pharma Industries Ltd. operates across various sectors in both the pharmaceutical and chemical industries, with a focus on specialty chemicals and intermediates, which find applications in Indian Le pharmaceuticals, paints, food products, and adhesives.
MUTUAL FUND LITE OR MF LIT PROMISING PROGRESS FOR INVESTORS
The SEBI has streamlined rules for passively managed schemes to have the impact of letting more players in the mutual fund ecosystem and offering diversified, low-risk investment options to retail investors. It would increase market liquidity and attract participation from old as well as new Asset Management Companies (AMCs). Shivanand Pandit feels that MF Lite is going to democratize investment opportunities in the Indian financial market.
GLOBALISM, FREEDOM & DEMOCRACY DO NOT MIX
The world today is packed with wealthy institutions and individuals that stand in revolt against the ideas of freedom and democracy. They do not like the idea of geographically constrained states with zones of juridical power.
BRICS Member States Ready to Dethrone Dollar
AS the US weaponises the dollar in the Russian and Iranian sanctions, there is increasing desire by other developing countries to seek alternative currencies for trade, investment, and reserves, as well as developing alternative multilateral clearance systems outside of SWIFT.
7 BEST PHARMA COMPANIES
The pharmaceutical industry in India is expected to reach $65 Bn by end of 2024 and to $130 Bn by 2030. India is a major exporter of Pharmaceuticals, with over 200+ countries served by Indian pharma exports. While Nifty's performance has been lackluster over the past month, several pharmaceutical stocks have shown resilience.
NEW INVESTMENT PRODUCT CATEGORY IS SEBI'S LATEST MOVE COMMENDABLE?
The Securities and Exchange Board of India (SEBI) has introduced a consultation paper proposing a new investment product category aimed at addressing a specific market need. This proposed asset class would offer investment options that sit between mutual funds (MFS) and PMS, filling a gap and providing greater flexibility in portfolio management. The new investment vehicle is designed for investors who are prepared to take on riskier market positions but find PMS schemes or AIFs out of reach. SEBI after reviewing the feedback and finalizing the regulations through stakeholder discussions, may issue the final regulations.
DECODING THE CHINA MYTH
Myths die hard. Among these is the great myth that China's poised to take over the world. Here, James Rickards debunks that myth.
What Is In Store For The Indian Economy?
Until the 2014 Lok Sabha elections, when the Bharatiya Janata Party secured 282 seats and Narendra Modi ascended to power, India experienced 21 years of coalition governments. A decade later, the BJP holds 240 seats in the Lok Sabha, and India is once again governed by a coalition. Fitch has indicated that coalition politics and a weakened mandate for the NDA could hinder the passage of ambitious reform legislation. It raises the question: Do coalition governments impede the economic reform agenda?